Historical Stock Price
SGMO historical stock prices picture
Sangamo Therapeutics (SGMO) has the following price history information. Looking back at SGMO historical stock prices for the last five trading days, on April 19, 2024, SGMO opened at $0.48, traded as high as $0.53 and as low as $0.47, and closed at $0.51. Trading volume was a total of 1.05M shares. On April 22, 2024, SGMO opened at $0.53, traded as high as $0.56 and as low as $0.48, and closed at $0.51. Trading volume was a total of 1.27M shares. On April 23, 2024, SGMO opened at $0.52, traded as high as $0.57 and as low as $0.51, and closed at $0.52. Trading volume was a total of 2.28M shares. On April 24, 2024, SGMO opened at $0.51, traded as high as $0.52 and as low as $0.49, and closed at $0.49. Trading volume was a total of 1.16M shares. On April 25, 2024, SGMO opened at $0.49, traded as high as $0.51 and as low as $0.46, and closed at $0.50. Trading volume was a total of 995.80K shares.

SGMO Historical Stock Prices By Date:

SGMO historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Sangamo Therapeutics shares, starting with a $10,000 purchase of SGMO, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/29/2014
End date: 04/25/2024
Start price/share: $13.74
End price/share: $0.50
Dividends collected/share: $0.00
Total return: -96.36%
Average Annual Total Return: -28.21%
Starting investment: $10,000.00
Ending investment: $363.94
Years: 10.00
Date Open High Low Close Volume
04/19/2024 $0.48 $0.53 $0.47 $0.51 1.05M
04/22/2024 $0.53 $0.56 $0.48 $0.51 1.27M
04/23/2024 $0.52 $0.57 $0.51 $0.52 2.28M
04/24/2024 $0.51 $0.52 $0.49 $0.49 1.16M
04/25/2024 $0.49 $0.51 $0.46 $0.50 995.80K
Sangamo BioSciences is a clinical-stage genomic medicine company focused on translating science into medicines. Co.'s clinical-stage product candidates are: Isaralgagene civaparvovec (ST-920), which is Co.'s wholly-owned gene therapy product candidate for the treatment of Fabry disease; SAR445136, which is Co.'s zinc finger nuclease gene-edited cell therapy product candidate for the treatment of sickle cell disease; TX200 for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; and Giroctocogene fitelparvovec (SB-525), which is a gene therapy product candidate for the treatment of moderately severe to severe hemophilia A.
Date Close
04/19/2024$0.51
04/22/2024$0.51
04/23/2024$0.52
04/24/2024$0.49
04/25/2024$0.50
SGMO is categorized under the Healthcare sector; below are some other companies in the same sector:

SGNL Historical Stock Prices
SGNT Historical Stock Prices
SGRY Historical Stock Prices
SGYP Historical Stock Prices
SHPG Historical Stock Prices
SHS Historical Stock Prices
SIEN Historical Stock Prices
SIGA Historical Stock Prices
SIGAQ Historical Stock Prices
SIRO Historical Stock Prices

Also explore: SGMO shares outstanding history

Email EnvelopeFree SGMO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


SGMO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.